^P.H. and Horhammer, L., Hager's Handbuch der Pharmazeutischen Praxis, Vols. 2-6, Springer-Verlag, Berlin, 1969-1979
^Taira, Zenei; Yabe, Kazunori; Hamaguchi, Yuka; Hirayama, Kensuke; Kishimoto, Makoto; Ishida, Shiro; Ueda, Yukari. Effects of Sho-saiko-to extract and its components, Baicalin, baicalein, glycyrrhizin and glycyrrhetic acid, on pharmacokinetic behavior of salicylamide in carbon tetrachloride intoxicated rats. Food and Chemical Toxicology (Elsevier BV). 2004, 42 (5): 803–807. ISSN 0278-6915. doi:10.1016/j.fct.2003.12.017.
^Wang H, Hui KM, Xu S, Chen Y, Wong JT, Xue H. Two flavones from Scutellaria baicalensis Georgi and their binding affinities to the benzodiazepine site of the GABAA receptor complex. Pharmazie. 2002, 57 (12): 857–8. PMID 12561253.
^Liao JF, Hung WY, Chen CF. Anxiolytic-like effects of baicalein and baicalin in the Vogel conflict test in mice. Eur. J. Pharmacol. 2003, 464 (2–3): 141–6. PMID 12620506. doi:10.1016/s0014-2999(03)01422-5.
^Awad R, Arnason JT, Trudeau V, Bergeron C, Budzinski JW, Foster BC, Merali Z. Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties. Phytomedicine. 2003, 10 (8): 640–9. PMID 14692724. doi:10.1078/0944-7113-00374.
^Tarragó, T; Kichik, N; Claasen, B; Prades, R; Teixidó, M; Giralt, E. Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor. Bioorganic & Medicinal Chemistry. 2008, 16 (15): 7516–24. PMID 18650094. doi:10.1016/j.bmc.2008.04.067.